If you’re suffering from mental health challenges, the last thing anyone wants to go through is a lengthy trial and error process with multiple medications. The process can be frustrating and leave people feeling worse, not better. Fortunately, the GeneSight genetic test can provide doctors answers that can quickly lead to relief. Pharmacogenomic testing helps empower your doctor with the information needed to prescribe the best medication for you. By examining how your DNA responds to specific medications such as antidepressants, this simple, painless test lets doctors know which medications may not work for you, so you can get back to feeling like yourself again. That’s the power and simplicity of the GeneSight test.
- + Depression, PTSD, Anxiety
PsychotropicIf you’ve been diagnosed with depression, anxiety, bipolar disease, schizophrenia or related conditions, GeneSight Psychotropic can help you shorten the road to recovery and escape the often long and frustrating process of trying multiple medications — like antidepressants. Through pharmacogenomic testing, your doctor can identify the correct medication and create a personalized treatment for you.
- + Acute or Chronic Pain
AnalgesicFor those experiencing acute or chronic pain, this genetic test analyzes how your genes affect your body’s response to FDA-approved opioids, NSAIDs and muscle relaxants to accurately determine which medications are optimal.
- + ADHD
ADHDIf you or your child have Attention-Deficit / Hyperactivity Disorder, this genetic test can help quickly and accurately determine which drugs will work best with your (or your child’s) genes.
- + Folate Deficiency
MTHFRThe active form of folic acid is integral to the production of dopamine, serotonin, and norepinephrine. This genetic test analyzes one important gene to determine if your body can covert folic acid into its active form of L-methylfolate.
GeneSight Testing Significantly Improved Remission Rates for Depression Compared to Treatment as Usual
Your doctor collects a DNA sample by painlessly swabbing the inside of your cheek
The sample is sent to our lab for analysis
Just 36 hours later, your personalized report is available for you and your doctor to review together
Guided by insights from your report, your doctor prescibes medication that complements your genes, and you will start feeling like you again
The Assurex Health Promise
Insurance can be complicated, and we want you to feel comfortable knowing what you’ll owe. We promise that if your cost could be more than $330, we’ll call you before we process your test.
Here is what you might owe for the GeneSight® test:
Medicare or Medicaid — If you have a traditional Medicare or Medicaid plan, your cost is $0
Medicare Advantage, Employer or other insurance may expect you to cover a portion of the cost. Plans vary, but the typical cost is $330 or less. If it’s more, we will contact you before we process your test. That’s the Assurex Health Promise.
Uninsured — Please contact us to find out how we can help.
By finding the right treatment sooner, the Genesight test can also help save on doctor visits and the cost of medications that don’t work.
One in six Americans develop Major Depressive Disorder (MDD) in their lifetime.6 Medications serve as the primary course of care for this condition, yet fewer than half of all depressed patients respond well to their first prescription and overall treatment failure rates exceed 50%. 7
That’s because medications aren’t one size fits all. Historically, doctors have not had the data and insight to personalize treatments, until now.
We developed GeneSight® to personalize the way medicine is prescribed and get you back on the path to hope– faster. Using our tests, doctors have helped over 750,000 patients discover which medications are the best match for their genes. GeneSight can do the same for you.
6. Kessler RC, et al. Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. doi:10.1001/archpsyc.62.6.593
7. Crown WH, et al. The impact of treatment-resistant depression on health care utiliza¬tion and costs. J Clin Psychiatry 2002 Nov; 63(11):963-71.
The development of the GeneSight® test in our clinical laboratory was based on patented technology licensed through our partnership with the Mayo Clinic and Cincinnati Children’s Hospital Medical Center, each renowned for innovation and research. Our Mason, Ohio-based lab is ranked at the highest level of accreditation, enabling us to continue our research and development of the GeneSight tests.